Arthur V. Martin Ph.D. is President of Global Infection Control Consultants, LLC headquartered in North Miami, FL. He has 40+ years global expertise managing and mitigating pathogenic bioaerosol contamination in buildings along with design and construction of critical controlled environments including Hospital Operating Suites, Pharmaceutical Clean Rooms and Biosafety Laboratories and High-Rise Residential Building environmental control.

Dr. Martin is considered one of the world’s foremost experts on the various technologies available to control the spread of disease. He is highly sought after for his expertise of selection of the most efficient and efficacious technology as required for a specific structure.

He has personally conducted more than 4,000 assessments globally in his career for chemical biological, bacterial and viral contamination. He pioneered the concept of “Prophylactic Air Management for Pathogen Control” and he has an extensive list of publications and peer reviewed awards and he has lectured worldwide on the subjects of Pathogen Control and Indoor Air Quality in buildings of all sizes, uses and physical construction.

A former ASHRAE member, his past projects have been recognized with 1st place Awards for Existing Health Care as well as Existing Institutional Buildings. One of his projects was voted the Most Efficient Building in The Nation. He is the Environmental Consultant to The Faisal Group of Companies in Riyadh, Kingdom of Saudi Arabia, a member of the W.H.O. Stop TB board, and a Member/Researcher of the Infectious Diseases International Research Initiative, Ankara, Turkey as well as a Collaborative Researcher with Camarines Norte State University, Daet, Philippines. Dr. Martin is also the Chief Scientist of a Tianjin, China Biotechnology company.

He is a past nominee for the W.H.O Kochon Prize for innovative work with T.B. in buildings thereby reducing treatment times and allowing more infected people to be treated quicker, more efficiently and less costly. In 2021 he was nominated for a Nobel Prize, specifically for innovative work with COVID-19 including development of an organic based, non-toxic anti-pathogenic product that can be mass produced and globally distributed. The product was tested and proven to kill COVID-19 in two (2) minutes or less. Along with the product, Dr. Martin conceptualized, designed, prototyped, patented and made available a delivery system that will automatically infuse the product into enclosed buildings.

Positions Held:

Awards:

Nominated for a Nobel Prize for research and development controlling Pathogenic Bioaerosols including COVID-19(SARS CoV2) organically. READ MORE

Nominated for The Kochon Prize awarded by W.H.O for work with Tuberculosis (T.B.)

Awarded Global Export Excellence Award by the United States Department of Commerce; U.S. Commercial Service.

ASHRAE 1st Place Award: Existing Health Care Facilities
ASHRAE 1st Place Award: Existing Institutional Buildings

Energy User News Magazine: Awarded Most Efficient Building in The Nation